Radiopharm Theranostics Ltd (RAD) — Financial Flexibility Index
Radiopharm Theranostics Ltd (RAD) has a Financial Flexibility Index of -0.55x as of December 2025. Free cash flow of AU$-22.67 Million (operating CF AU$-22.67 Million minus capex AU$4.00) represents -1% of total liabilities (AU$41.23 Million). Also explore Radiopharm Theranostics Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Radiopharm Theranostics Ltd Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Radiopharm Theranostics Ltd across 5 annual periods. Check how strategically is Radiopharm Theranostics Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Radiopharm Theranostics Ltd (2021–2025)
Year-by-year free cash flow to debt coverage for Radiopharm Theranostics Ltd. For the full company profile including market capitalisation, see RAD market cap.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.84x | AU$-36.65 Million | AU$-36.65 Million | AU$43.61 Million | ▼ -63.4% |
| 2024 | -0.51x | AU$-22.98 Million | AU$-22.98 Million | AU$44.68 Million | ▲ +30.3% |
| 2023 | -0.74x | AU$-21.67 Million | AU$-23.20 Million | AU$29.37 Million | ▼ -181.7% |
| 2022 | 0.90x | AU$18.43 Million | AU$-9.91 Million | AU$20.42 Million | ▲ +573.3% |
| 2021 | -0.19x | AU$-30.16K | AU$-32.91K | AU$158.14K | — |